HYQVIA sol perf 20 g/200ml double flacons 200 ml

7680666840047 CH-66684 J06BA01 08.09.

Reimbursement limitations:

HYQVIA.01

Pour le traitement des syndromes provoqués par l'absence d'anticorps et de la polyneuropathie démyélinisante inflammatoire …

HYQVIA sol perf 20 g/200ml double flacons 200 ml
HYQVIA sol perf 20 g/200ml double flacons 200 ml
HYQVIA sol perf 20 g/200ml double flacons 200 ml
1 / 3
google

Details

Product number
6668401
CPT
-
Packaging group
1 + 1
Unit
Durchstechflasche(n)
Composition
I) Durchstechflasche mit humanem normalem Immunglobulin: immunoglobulinum humanum normale 100 mg, glycinum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. II) Durchstechflasche mit rekombinanter humaner Hyaluronidase: hyaluronidasum humanum ADNr, dinatrii phosphas, natrii hydroxidum, calcii chloridum anhydricum, natrii chloridum, dinatrii edetas, albumini humani solutio, acidum hydrochloridum ad pH, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 4.03 mg.

Articles (1)

HyQvia 100 mg/ml, Infusionslösung zur subkutanen Anwendung
Infusionslösung
1 + 1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
04/09/2025
Patient information leaflet
Français
04/09/2025
Patient information leaflet
Italien
04/09/2025
Professional SmPC
Allemand
04/09/2025
Professional SmPC
Français
04/09/2025
Professional SmPC
Italien
04/09/2025

Detailed composition

Substance Quantity Type Category
II
- Substance HIMDK
I
100.0 MG Substance Wirkstoff (Principe actif)
II
- Substance HNIDK
I
- Substance HIMDK
I
- Substance HNIDK
II
- Substance HIMDK
II
- Substance HNIDK
II
- Substance HIMDK
II
- Substance HIMDK
II
- Substance HNIDK
II
- Substance HIMDK
II
- Substance HNIDK
II
4.03 MG Substance HBESI

Reimbursement information

Public price
CHF 1457.15
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2020

Authorization holder

Takeda Pharma AG

8152 Opfikon

Authorization information

Swissmedic authorization number
66684
Drug name
HyQvia, Infusionslösung zur subkutanen Anwendung
Galenic form
LSINF
ATC Code
J06BA01
Authorization status
Z
Dispensation category
B
First authorization
08/01/2020
Authorization expiration date
31/12/9999
IT number
08.09.
Domain
Human medicine
Field of application
Substitutionstherapie bei Erwachsenen mit primärem Immundefektsyndrom mit unzureichender Antikörperbildung; Substitutionstherapie bei Erwachsenen mit Sekundären Immundefekten (SID).

Packaging details

Description (FR)
HYQVIA sol perf 20 g/200ml double flacons 200 ml
Description (DE)
HYQVIA Inf Lös 20 g/200ml Dual Flaschen 200 ml
Market launch
08/01/2020
Narcotic (BTM)
No

Other packaging sizes

HYQVIA sol perf 2.5 g/25ml double flacons 25 ml
1 + 1 DUR
GTIN: 7680666840016
View
HYQVIA sol perf 5 g/50ml double flacons 50 ml
1 + 1 DUR
GTIN: 7680666840023
View
HYQVIA sol perf 10 g/100ml double flacons 100 ml
1 + 1 DUR
GTIN: 7680666840030
View
HYQVIA sol perf 30 g/300ml double flacons 300 ml
1 + 1 DUR
GTIN: 7680666840054
View